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Background: Diluted bee venom (BV) is known to have anti-nociceptive and anti-inflammatory effects. We therefore
assessed whether perineural bee venom pretreatment could attenuate the development of neuropathic pain in
the spinal nerve ligation injured animal model.
Methods: Neuropathic pain was surgically induced in 30 male Sprague Dawley rats by ligation of the L5 and L6
spinal nerves, with 10 rats each treated with saline and 0.05 and 0.1 mg BV. Behavioral testing for mechanical, cold,
and thermal allodynia was conducted on postoperative days 3 to 29. Three rats in each group and 9 sham operated
rats were sacrificed on day 9, and the expression of transient receptor potential vanilloid type 1 (TRPV1), ankyrin type 1
(TRPA1), and melastatin type 8 (TRPM8) receptors in the ipsilateral L5 dorsal root ganglion was analyzed.
Results: The perineural administration of BV to the spinal nerves attenuated the development of mechanical, thermal,
and cold allodynia, and the BV pretreatment reduced the expression of TRPV1, TRPA1, TRPM8 and c − Fos in the
ipsilateral dorsal root ganglion.
Conclusion: The current study demonstrates that the perineural pretreatment with diluted bee venom before the
induction of spinal nerve ligation significantly suppresses the development of neuropathic pain. Furthermore, this bee
venom induced suppression was strongly related with the involvement of transient receptor potential family members.
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Traditionally, bee venom (BV) has been utilized in alterna-
tive and complementary medicine to treat and relieve pain
in patients with rheumatoid arthritis and osteoarthritis [1].
In oriental alternative medicine, the injection of BV into an
acupuncture point, a practice called apipuncture, has been
believed to relieve pain and inflammation, restoring normal
body functions [1,2]. By contrast, the BV has been found to
be a potent nociceptor that causes pain and inflammation,* Correspondence: jaljary@naver.com; sjinwoo@hotmail.com
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unless otherwise stated.as well as causing potent allergic reactions in sensitized
individuals [3-6].
The nociceptive and inflammatory effects of BV have
made it useful in developing animal models of inflamma-
tory pain. Since its introduction [4], the BV pain test has
been used widely in experimental studies [3]. For example,
subcutaneous injection of BV into rat hind paws induces
inflammation in that paw, as well as primary thermal and
mechanical hyperalgesia, secondary thermal hyperalgesia,
and mirror image heat hyperalgesia [3,7].
Paradoxically, diluted BV (DBV) has been shown to
have anti-nociceptive and anti-inflammatory properties.
Most experimental animal studies with DBV have focused
on its effects and mechanisms of action during injections
into acupuncture points, mostly at the Zusanli point, an. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ous studies have revealed that the anti-nociceptive and
anti-hyperalgesic effects of DBV are strongly associated
with alpha2-adrenoreceptor activation and capsaicin
insensitive primary afferent fibers, but not with opioid
receptors [9,11]. The anti-arthritic effects of DBV have been
shown to involve the inactivation of nuclear factor kappa B,
which inhibits the release of inflammatory cytokines [12],
and an increase in endogenous glucocorticoid concentra-
tion [13]. The specificity of BV in acupoint injection is
unclear, as the injection of chemical irritants other than BV
into the Zusanli acupuncture point also produced signifi-
cant anti-nociceptive effects [14]. Moreover, when the tran-
sient receptor potential (TRP) cation channel family was
investigated, the involvement of capsaicin–sensitive and –
insensitive afferents in the anti-nociceptive mechanism of
BV yielded conflicting results [11,14].
The mechanisms underlying the anti-allodynic effects
of BV are unclear. Acupoint injection of DBV in animals
with peripheral nerve injury was shown to increase the
threshold against thermal and cold stimuli [9]. The
sensitization of TRP receptor families has been found to
play an important role in the development of cold and
thermal allodynia [15-17].
In the present study, we tested the hypothesis that peri-
neural DBV pretreatment may attenuate the development
of neuropathic pain, and that DBV may desensitize TRP
cation channel sensitive nociceptive afferents, including
vanilloid type 1 (TRPV1), ankyrin type 1 (TRPA1), and
melastatin type 8 (TRPM8) receptors, which may result in
anti-nociceptive and anti-allodynic effects in the rat spinal
nerve ligation (SNL) injury model of neuropathic pain.
Methods
Experimental animals
The study protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) of Asan
Medical Center. Male Sprague Dawley rats (Orient Bio,
Sungnam, Korea), weighing 180–200 g, were housed
individually for 7 days in humidity and temperature con-
trolled (21 ± 1°C) vivaria, with a 12-hour night/day cycle
(07:00 hr onset) and free access to food and water at all
times, before use in experiments. Behavioral testing and
analgesiometry were performed according to the ethical
guidelines set by the IACUC of Asan Medical Center,
and the animals were euthanized after completion of
planned tests.
Experimental groups and drug preparation
Neuropathic pain was surgically induced in 30 male rats
by ligation of the L5 and L6 spinal nerves [18], with 10
rats each treated with saline and 0.05 and 0.1 mg DBV.
Three rats in each group were sacrificed 9 days postopera-
tively for immunohistochemical assay, and behavioral testresults were obtained from seven rats in each group. Sham
surgery without nerve ligation was also performed in 3 rats
per experimental group (total 9 rats) for reference data.
Bee venom was extracted from Apis mellifera
(Apitoxin®Guju Pharm., Seoul, Korea) and dissolved in
0.9% normal saline at concentrations of 1 μg/μL and
2 μg/μL. The experimenter was blinded to the compos-
ition of the experimental drug administered.
The induction of neuropathic pain and DBV treatment
The animals were anesthetized by intraperitoneal injection
of zoletil (12.5 mg) and xylazine (3 mg) and placed on the
operating table. An approximately 1.5 cm midline incision
was made on the left lateral side of each rat at the L5–L6
level. The paravertebral muscles were dissected and
retracted, and the L5 and L6 vertebral bodies were par-
tially exposed. The left L5 transverse process was partially
excised and the left L5 and L6 spinal nerves were exposed.
DBV solution or normal saline was injected into the peri-
neural sheath of the L5 and L6 spinal nerves using a
microinjection syringe. Approximately 5 mm of the
exposed spinal nerves were bathed for 5 min with DBV
solution or normal saline. The wound was closed with 4-0
black silk (AILEE, Busan, Korea) sutures and the animals
were allowed to recover. One hour after full recovery, the
animals were again anesthetized and the spinal nerves
were again exposed as described above, and neuropathic
pain was surgically induced by ligation of the L5 and L6
spinal nerves as previously described [18].
Behavioral assessment
To eliminate the effect of errors associated with diurnal
rhythm, all behavioral tests were performed at the same
time of the day. Behavioral testing for mechanical, cold,
and thermal allodynia was performed, starting from
postoperative day 3, on the injured ipsilateral hindpaw.
For the mechanical and cold allodynia tests, the rats
were placed in individual acrylic cages with a wire mesh
floor and were allowed to habituate for 30 min. The tactile
threshold for mechanical allodynia was measured by
applying eight calibrated von Frey filaments (0.41–15.1 g;
Stoelting Co., Wood Dale, IL, USA) to the palm of the in-
jured ipsilateral hind paw. Sufficient pressure was applied
for 6 seconds to cause slight bending of the filament
against the midplantar surface of the injured hind paw,
with a brisk withdrawal or flinching of the paw considered a
positive response. The 50% withdrawal threshold was deter-
mined by using the up-down method [19]. The cut-off value
was defined as the absence of response to 15.1 g force.
Cold allodynia against chemical stimuli was tested using
the acetone drop application technique [20]. Briefly, a drop
of acetone was applied five times, at intervals of 3 minutes,
to the midplantar surface of the injured ipsilateral hind
paw using a syringe connected to a thin polyethylene tube,
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acetone was recorded.
Thermal allodynia and cold allodynia against heat was
analyzed using a hot/cold plate apparatus (UgoBasile,
Comerico, Italy) [21]. For thermal allodynia testing, each
rat was placed on the hot plate device, with the
temperature adjusted to 42 ± 0.1°C. For cold allodynia
testing, the same device was used with the temperature
adjusted to 10 ± 0.1°C. The latency to first nocifensive
behavior (hind paw withdrawal or liking) was regarded
as an index to nociceptive threshold. Each rat was tested
three times with sufficient intervals between trials to
avoid possible effects of anesthesia or tissue damage.
The cut-off time was set at 30 seconds for thermal and
100 seconds for cold allodynia to prevent possible tissue
damage to the affected paw.
Baseline values were determined by performing these
behavioral tests 1 day prior to neuropathic surgery.
Behavior was also measured at 3, 5, 7, 9, 13, 17, 21, 25,
and 29 days after neuropathic pain surgery and drug
administration. The mechanical withdrawal threshold
was reported as actual threshold in grams (g); the with-
drawal frequency in response to cold stimuli per rat was
reported as percentage (%), by dividing the number of
paw withdrawals by five and multiplying the result by
100; and the withdrawal latency against heat and cold
was reported as elapsed time (s) until the start of the
withdrawal response.
Immunohistochemistry
Three rats in each group and 9 sham operated rats were
sacrificed on postoperative day 9. The animals were
anesthetized by intraperitoneal injection of zoletil
(12.5 mg) and xylazine (3 mg), and fixative containing
4% buffered paraformaldehyde was perfused through the
left ventricle. The left L5 DRG from the rats were
dissected and fixed immediately in the same solution.
Tissue samples were embedded in paraffin, and the
blocked sections were cut (10 μm) with a microtome
and then mounted onto slides. These samples were
deparaffinized with three changes of xylene for 5 minutes
each, and hydrated in 100% and 95% ethanol for 10 minutes
each and in 70% ethanol for 5 minutes, and rinsed twice in
distilled water for 5 minutes each. The slides were im
mersed in 0.01 M sodium citrate buffer (pH 6.0), which
was heated at 95°C for 15 minutes. The immersed slides
were then allowed to cool in air for 30 minutes. The
sections were blocked with 5% normal donkey serum, 0.3%
Triton X-100 and 1% bovine serum albumin (BSA) in
phosphate buffered saline–Tween (PBS-T) for 1 hour.
The sections were subsequently incubated overnight at
4°C with rabbit polyclonal antibodies to TRPV1 (1:1000;
ab31895, Abcam, Cambridge, UK), TRPA1 (1:1000;
ab68847, Abcam, Cambridge, UK), or TRPM8 (1:1000;ab104569, Abcam, Cambridge, UK); with the IgG fraction
of mouse polyclonal antibody to neurofilament 200KDa
(NF200), a marker of myelinated neurons (1:1000; n0142,
Sigma, St Louis, MO); or with the IgG fraction of sheep
polyclonal antibody to c–Fos, an indicator of neuronal
activity (1:100; LS–C93966, LSBio, Seattle, WA). Sections
incubated with antibodies to TRPV1, TRPA1, and TRPM8
\were subsequently incubated with Alexa Flour 546 donkey
anti-rabbit IgG (red; 1:1000; Invitrogen, Carlsbad, CA) for
2 hours at room temperature. Sections incubated with anti-
bodies to NF 200 and c-fos were subsequently incubated
with Alexa Flour 488 donkey anti-mouse IgG (green;
1:1000; Invitrogen, Carlsbad, CA) and Alexa Flour 350 don-
key anti-sheep IgG (blue; 1:1000; Invitrogen, Carlsbad, CA),
respectively. The sections were rinsed in PBS-Tandmounted
onto slides, and immunofluorescence was assayed using a
confocal fluorescent microscope (Olympus BX51 system
microscope, Tokyo, Japan) with imaging software (Image
Pro Plus ver. 5.1, Media Cybernetics, Rockville, MD, USA).
The number of immunoreactive (IR) cells was counted in
six slices of the DRG for each group. The percentages of IR
cells, doubly and triply labeled cells were calculated by div-
iding the observed numbers of these cells by the total num-
ber of cells observed in the field and multiplying by 100.
Statistical analysis
All data are presented as means ± standard errors
(SEM). Behavioral results were compared in the experi-
mental and control groups by two-way repeated measure
of analysis of variance (ANOVA) followed by post–hoc
analysis using the Holm–Sidak test. The percentages and
numbers of TRPV1, TRPA1, and TRPM8 positive cells
in the DRG were compared using the Kruskal–Wallis
test or the chi-square test, as appropriate. SigmaPlot
version 12.0 (Systat Software Inc, Richmond, CA, USA)
was used for data analysis. P < 0.05 was considered
statistically significant.
Results
The results of behavioral testing after DBV treatment
The perineural pretreatment of the L5 and L6 spinal
nerves with DBV significantly attenuated the develop-
ment of mechanical allodynia. The mechanical hind paw
withdrawal threshold (PWT) was significantly higher in
rats treated with 0.05 mg and 0.1 mg DBV on days 3, 5,
7, 9 and 13 compared with the saline treated control
group animals (Figure 1). Although surgically treated
control animals developed significant cold allodynia
against acetone stimulation, rats perineurally treated with
DBV showed inhibition of cold allodynia development,
producing significantly lower paw withdrawal frequency
(PWF). This inhibition of cold allodynia in the both DBV
treated groups was observed on the first day of behavioral
testing and continued until the end of the study, lasting
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DBV also significantly inhibited the development of both
thermal and cold allodynia against hot/cold plate test,
producing a significantly higher threshold in hind paw
withdrawal latency (PWL) than control rats (Figure 1).
This inhibition against temperature stimulation presented
to be dose related. Significant greater inhibition of thermal
and cold allodynia was observed in rats treated with
0.1 mg than with 0.05 mg group DBV. Beginning on dayFigure 1 The results of behavioral testing after perineural diluted bee
allodynia was suppressed in rats pretreated with diluted bee venom (DBV),
DBV treated groups were significantly higher compared with the control g
stimulation test in rats. Cold allodynia was inhibited, beginning on day 3 in
group and continued until the end of study. C. DBV effect on hot plate tes
0.1 mg DBV group, and day 9 to day 17 in 0.05 mg DBV group. The PWL o
beginning on day 21. The preservation of PWL was dose related, being sig
days 3, 5, 7, 9, and 13. D. DBV effect on cold plate test in rats. The develop
with DBV, especially in the 0.1 mg group, beginning on day 5 until the end
compared with 0.05 mg group throughout the study period. Each point re
with the control group. †p < 0.05 compared with the BV 0.05 mg group. n21, however, response to thermal stimuli was diminished
in both DBV treated and control groups, with the PWL
restored to preoperative values. In contrast, the response
to cold plate test was inhibited until the end of the study.
Immunohistochemical analysis of the DRG
Compared with the sham operated group, the surgically
treated control group showed a significant increase in
the proportion of TRPV1 expressing neurons in thevenom (DBV) pretreatment in time–course. A. Mechanical
relative to the control group. The paw withdrawal threshold in both
roup from observation day 3 to day 13. B. DBV effect on acetone
both groups of rats treated with DBV, compared with the control
t in rats. Thermal allodynia was inhibited from day 3 until day 17 in
f control and both BV treated groups restored to normal values
nificantly higher in rats treated with 0.1 mg than with 0.05 mg DBV on
ment of cold allodynia after SNL was inhibited in the rats pretreated
of study. The 0.1 mg DBV group presented significantly longer PWL
presents mean ± standard error of the mean (SEM). *p < 0.05 compared
= 7 animal per group.
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in the DRG of the both DBV treated group was signifi-
cantly reduced compared with the control group
(Figures 2 and 3). SNL surgery resulted in a significant
increase in TRPA1–IR cells in NF200 negative unmy-
elinated neurons compared with the sham operated
group (p < 0.05). DBV pretreatment significantly reduced
the numbers of TRPA1–IR cells in both myelinated and
unmyelinated neurons when compared with the control
group. In the unmyelinated neurons, greater reduction
of TRPA1–IR cells was observed in the BV 0.1 mg group
compared with the BV 0.05 mg group, but a similar dose
relationship was not observed in myelinated neurons
(Figures 2 and 3). SNL surgery also induced a significant
increase in the number of TRPM8–IR cells in bothFigure 2 The proportion of immunoreactive (IR) neurons observed at
proportion of A. transient receptor potential vanilloid type 1 (TRPV1), B. ank
neurons. Compared with sham operated animals, spinal nerve ligation surg
200 positive neurons presenting immunoreactivity for TRPV1, TRPA1, TRPM
increased the proportion of TRPV1, TRPM8 and c–Fos IR neurons in the do
diluted bee venom (DBV) significantly decreased the proportion of NF 200
c–Fos compared with the control group. Three rats in each group were an
*p < 0.05 compared with the control group, † p < 0.05 compared with themyelinated and unmyelinated neurons (p < 0.05), and
DBV pretreatment suppressed the expression of TRPM8
in the DRG of SNL animals. Similarly with TRPA1
expression, a greater reduction in the number of un-
myelinated TRPM8–IR neurons were observed in the
BV 0.1 mg group compared with the 0.05 mg group
(Figures 2 and 3).
The SNL surgery resulted in robust increases in c–Fos
immunoreactivity (Fos–IR) in both myelinated and
unmyelinated neurons (p < 0.05, Figures 2 and 3). DBV
pretreatment significantly reduced the number of Fos–
IR neurons in the DRG compared with the control
group and in the unmyelinated neurons, the suppression
of c–Fos activity was greater in the BV 0.1 mg group
compared with BV 0.05 mg.the ipsilateral L5 dorsal root ganglion (DRG). Histograms show the
yrin type 1 (TRPA1), C. melastatin type 8 (TRPM8) and D. c–Fos IR
ery (SNL) significantly increased the proportion of neurofilament (NF)
8 and c–Fos. In the NF200 negative neurons, SNL surgery significantly
rsal root ganglion. Perineural pretreatment with 0.05 mg or 0.1 mg
positive and negative neurons expressing TRPV1, TRPA1, TRPM8 and
alyzed. Each bar represents mean (%) ± standard deviation (SD).
BV 0.05 mg group.
Figure 3 Immunofluorescent images of dorsal root ganglion. A. Transient receptor potential vanilloid type 1 (TRPV1) immunoreactive (IR)
neurons and merged images with neurofilament (NF) 200 and c–Fos observed through a confocal microscope. Immunofluorescent images showing
neurons positive for TRPV1 (red), NF200 (green) and c–Fos (blue) in the dorsal root ganglion (DRG) 9 days after surgery in a) sham operated, b) spinal
nerve ligation (SNL), and c) 0.1 mg diluted bee venom (DBV) treated SNL rats. Clockwise from upper left: c–Fos– NF200 –merged – TRPV1. B. Transient
receptor potential ankyrin type 1 (TRPA1) IR neurons and merged images with NF200 and c–Fos. Neurons positive for TRPA1 (red), NF200 (green) and
c–Fos (blue) in the DRG 9 days after surgery in a) sham operated, b) SNL, and c) 0.1 mg DBV treated SNL rats. Clockwise from upper left: c–Fos– NF200 –
merged – TRPA1. C. Transient receptor potential melastatin type 8 (TRPM8) IR neurons and merged images with NF200 and c–Fos observed through a
confocal microscope. Neurons positive for TRPM8 (red), NF200 (green) and c–Fos (blue) in the DRG 9 days after surgery in a) sham operated, b) SNL,
and c) 0.1 mg DBV treated SNL rats. Clockwise from upper left: c–Fos– NF200 –merged – TRPA1. All images are magnified × 630, with scale bars = 40 μm.
Three rats in each group were analyzed.
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We examined the ability of perineurally administered
DBV to inhibit the development of neuropathic pain in
an animal model. Perineural pretreatment with DBVdemonstrated inhibition in the development of mechan-
ical, cold and thermal allodynia.
Several studies have examined the effects of DBV on
neuropathic pain. DBV injection into the acupuncture
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in pain sensitivity and inflammatory reactions, as well as
decreasing neuronal immunoreactivity in the spinal cords
of animal pain model [8,9]. A single subcutaneous injec-
tion of DBV into the Zusanli acupoint was shown to ef-
fectively decrease responses to thermal and cold stimuli in
neuropathic animals, but did not attenuate mechanical
allodynia [9,10,22]. Furthermore, repeated subcutaneous
injections of DBV into the acupoint alleviated mechanical
allodynia in the chronic constriction injury (CCI) model
of neuropathic pain [23]. The behavioral results in our
study were similar with these previous findings.
The mechanism of these anti–nociceptive effects of
DBV is not clear and under investigation. The spinal
alpha-2 adrenergic pathway has been shown to be im-
portant for the anti-nociceptive effects of DBV acupunc-
ture in formalin induced inflammatory pain and CCI
neuropathic pain models [9,10,22,23]. By contrast, opioid
receptors were not involved in the anti-nociceptive
mechanism of DBV injection, whereas the involvement
of capsaicin sensitive afferents is unclear [3,14]. One
study found that the effects of BV acupuncture were
mediated through capsaicin insensitive primary afferents
[11], whereas another study suggested that capsaicin
sensitive primary afferent fibers are partially involved in
the anti-nociceptive effects of DBV treatment [14]. We
found that DBV significantly reduced the proportion of
TRPV1–IR neurons at the DRG in the SNL model of
neuropathic pain, suggesting that DBV pretreatment
have down–regulated the activity of capsaicin sensitive
afferent neurons. This down–regulation may be one of
the mechanisms underlying the anti-nociceptive effects
of DBV, especially in maintaining thermal threshold.
The development of thermal hyperalgesia following
subcutaneous BV injection was highly associated with
increased TRPV1 expression in the spinal dorsal horn,
making BV a useful agent for inflammatory pain modeling
[24-27]. The reasons for these contradictory activities of
BV on TRPV1 receptors are currently unknown, but may
be due to different locations and doses of BV injections.
The BV is composed of numerous bioactive compounds,
which may have different effects depending on the site of
application, even at the same dose [8,9,14,23]. We injected
rats with 0.05 mg or 0.1 mg BV dissolved in 50 μL of
normal saline, doses chosen in reference to effective anti–
nociceptive doses [8,9]. The dose required for a robust
and prolonged pain response in rats is known to be ≥
0.2 mg, although lower doses, under 0.05 mg, induced a
short, mild pain response [14].
DBV injection was recently reported to significantly
reduce cold allodynia in the CCI neuropathic pain model
[22]. Our results are consistent with these findings, as BV
pretreatment significantly suppressed the development of
cold allodynia. We also assessed the involvement ofTRPA1 and TRPM8 receptors in the reduction of pain
behaviors in response to cold stimuli. Both TRPA1 and
TRPM8 expressions are increased following peripheral
nerve injury and mRNAs encoding both were significantly
increased after CCI surgery and were correlated with the
onset of cold allodynia [28]. The TRPA1 receptor is
important in the development of cold and mechanical
allodynia in inflammatory and neuropathic pain models
[29-32]. Increased expression of TRPA1 in A-δ fibers plays
a major role in the development of cold hypersensitivity in
the SNL injury model [33]. Our results were consistent
with these findings, as we observed no increase in the
proportion of unmyelinated NF200 negative TRPA-IR
neurons, but a significant increase in myelinated NF200
positive TRPA-IR neurons after SNL in the DRG. We also
found that BV pretreatment down–regulated the expres-
sion of TRPA1 receptors in both myelinated and unmy-
elinated fibers, which seemed to have resulted in the
attenuation of cold allodynia. The TRPM8 receptor is also
involved in the development of cold allodynia, and the de-
creased expression of TRPM8 receptors after intrathecal
application of TRPM8 antisense oligonucleotide resulted
in decreased sensitivity to cold stimuli in the CCI model
[34]. However, discordant results on the involvement of
TRPM8 in cold allodynia have been reported. In the SNL
model, TRPM8 was a minor component while and TRPA1
was the major component in the development of cold
nociception [31]. In our observation, TRPM8 expression
was significantly increased at the ipsilateral L5 DRG in
both myelinated and unmyelinated neurons after SNL
injury, along with increased responses to cold and mech-
anical stimuli. The expression of TRPM8 receptors was
significantly reduced after DBV pretreatment, indicating
that both TRPA1 and TRPM8 are involved in the develop-
ment of cold allodynia in the SNL injury model.
For immunohitochemical analysis, we chose day 9
because the peak response to stimuli in the SNL neuro-
pathic model occurs between days 5 and 14 [18]. Since
the effects of DBV on mechanical allodynia was shorter
lived than its effects on cold or thermal allodynia, the
relative proportions of TRPV1, TRPA1 and TRPM8-IR
neurons may have varied over time, and the result of cell
counting may have changed if the immunohistochemical
assay was performed at a different period.
Conclusion
In conclusion, the perineural pretreatment of DBV effect-
ively inhibited the development of neuropathic pain in the
SNL animal model. DBV induced long-lasting inhibition of
mechanical, thermal and cold allodynia. DBV-induced anti-
nociception was apparently due to its inhibition of TRPV1,
TRPA1, and TRPM8 receptors. Investigation of BV compo-
nents may help in developing therapeutic modalities to
treat neuropathic pain.
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